Fosravuconazole L-lysine ethanolate

DESCRIPTION

Fosravuconazole L-lysine ethanolate (BMS-379224 L-lysine ethanolate) is a broad-spectrum antifungal agent. In Japan, it is approved for the treatment of onychomycosis, a fungal infection of the nail. It is a prodrug that is converted into ravuconazole.

DETAILS

Cas: 914361-45-8
Purity: 95%
Smiles: N#CC1=CC=C(C2=CSC([C@H](C)[C@@](OCOP(O)(O)=O)(C3=CC=C(F)C=C3F)CN4N=CN=C4)=N2)C=C1.CCO.N[C@H](C(O)=O)CCCCN
Category: Compound
Molecular Weight: 739.7
Molecular Formula: C31H40F2N7O8PS

Lead Time: 4 - 5 weeks